News

Mercodia and Attana Partner for Preclinical Bioanalysis Mercodia and Attana are joining forces to develop next-generation solutions for preclinical drug development. By combining Mercodia’s bioanalyti...

Why Diabetes Awareness at Work Matters November 14 marks World Diabetes Day, a global initiative to raise awareness and inspire action for people living with diabetes. This year’s theme, “Know more an...

We are a Di Gasell award winner – again! We’re proud to share that Mercodia has once again been named a Di Gasell company by Dagens industri – for the sixth time. This is a rare achievement that only ...

Immunoassays for cardiometabolic biomarker measurement Cardiometabolic diseases, including diabetes, obesity, and cardiovascular conditions, are among the most pressing global health challenges. At Me...

Designed for Human Insulin Detection We are proud to introduce the Insulin MBeads Assay (10-1371-01), a high-throughput solution for accurate and efficient quantification of human insulin in vitro. De...

In 2024, we achieved 33 percent growth, bringing our total growth to 70 percent over the past three years. This reflects our long-term focus on delivering high-quality bioanalytical services and innov...

Which insulin assay should you choose? Selecting the correct insulin assay is essential for obtaining accurate and reliable results. Whether you are analyzing insulin in plasma, serum, cell culture me...

Mercodia recently completed a comprehensive assessment of our sustainability practices with EcoVadis, a global leader in sustainability evaluations. As part of our commitment to sustainability, we con...

Building a Comprehensive Data Transfer Agreement: Best practices and hands-on experience Wednesday, October 30, 2024 | 1:15 pm EDT (NA) / 6:15 pm CET | 30 min, or on-demand Don’t miss our AAPS-h...